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Primary bronchial mucoepidermoid carcinoma in the lung is relatively rare. It rarely presents with the highly malignant
biological characteristic of bone marrow metastasis. We describe a case of this disease with bone marrow
metastasis. A 56-year-old man with the primary manifestation of bone pain and bloodstained sputum had two
abnormal shadows on the left inferior lobar bronchus and peripheral tissue of the lower lobe of the left lung,
respectively. Computed tomography-guided percutaneous puncture biopsy and bone imaging confirmed the
diagnosis of high-grade bronchial mucoepidermoid carcinoma with bone metastasis. However, the patient soon
presented with progressive hemoglobin and platelet decline and severe multi-organ hemorrhage. Subsequently, we
performed bone marrow aspiration and biopsy, which revealed malignant cells and necrosis. The patient deteriorated
rapidly from the disease, and died on the 16th day of admission. We hope that this case report will increase awareness
of the possibility of primary high-grade bronchial mucoepidermoid carcinoma metastasizing to the bone marrow,
which might be a poor prognostic factor.
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Primary bronchial mucoepidermoid carcinoma, a low-
malignant potential tumor of bronchial gland origin, is
relatively rare and comprises approximately 0.1% of all
malignant lung tumors [1]. Compared with most other
lung cancers, it occurs in relatively young people [2-4].
Although mucoepidermoid carcinomas are malignant
tumors, they are usually indolent, with chronic progres-
sion. Surgical treatment yields a favorable prognosis; the
5-year survival rate is 95% and adjuvant treatment is
considered unnecessary. Mucoepidermoid carcinomas
rarely present highly malignant biological characteristics,
especially bone marrow metastasis. We report a case of
unusually aggressive bronchial mucoepidermoid car-
cinoma with bone marrow metastasis with the aim of
raising awareness of the malignant biological behavior of
this tumor.* Correspondence: drlhdong@163.com
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A 56-year-old man presented to our hospital complain-
ing of osphyalgia, dorsalgia, and melosalgia for 2 months,
and bloodstained sputum for 2 weeks. He had been a
drinker and smoker for more than 30 years, but de-
nied personal or family history of cancer. Physical
examination on admission disclosed vertebral tender-
ness. Routine blood examination revealed slightly de-
creased hemoglobin (HGB, 10.5 g/dL) and platelets
(PLT, 87,000/mm3). On chest computed tomography
(CT), we observed two lobulated masses measuring 30
to 40 mm in diameter in the left inferior lobar bronchus
(Figure 1A) and peripheral tissue of the lower lobe of
the left lung (Figure 1B), respectively. We also observed
left hilar lymph nodes enlargement. Magnetic resonance
imaging confirmed multiple sites of bone destruction of
the lumbar spine, and bone scans revealed systemic
multiple abnormal hypermetabolic lesions (Figure 2).
Based on the clinical and auxiliary examination find-
ings, the presumptive diagnosis was lung cancer with
multiple bone metastases.
On his third day in hospital, the patient underwent
CT-guided percutaneous puncture biopsy of the lung
and received palliative radiotherapy for the areas with. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Enhanced CT scan revealing two lobulated masses measuring 30 to 40 mm in diameter in the left inferior lobar bronchus (A)
and peripheral tissue of the lower lobe of the left lung (B), respectively.
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lung biopsy were poorly differentiated mucoepidermoid
carcinoma (Figure 3A). Ki-67 expression was about 70%.
Immunohistochemical examination revealed tumor cells
were positive for cytokeratin (CK) 7, CK5/6, and thyroidFigure 2 Technetium-99 m methylene diphosphonate bone
scintigraphy showing metastatic involvement of the thoracic
vertebra, humeri, and ribs.transcription factor-1 (TTF-1) (Figure 3B-D), which
allowed us to determine that his condition was primary
lung cancer. On the sixth day of admission, he presented
with mild hemoptysis; routine blood examination re-
vealed clearly decreased HGB and PLT, which were
6.2 g/dL and 56,000/mm3, respectively. As we suspected
bone marrow infiltration by the cancer cells, we stopped
radiotherapy and suggested that he undergo bone mar-
row aspiration and biopsy. However, he continued to de-
teriorate. Eight days later, we repeated the laboratory
tests; Table 1 lists the results. We did not find skin pe-
techiae or ecchymosis, or other evidence of bleeding. To
carry out further examinations and prevent the risk of
severe bleeding, we started supportive treatment com-
prising drug hemostasis and transfusion of platelet, fresh
frozen plasma, and red blood cell suspension. However,
the patient presented with upper gastrointestinal bleed-
ing without any obvious cause the following day, which
we suspected was stress ulceration bleeding. Thus, we
administered gastrointestinal decompression and gastric
acid inhibition.
Eleven days later, his PLT count rose to 63,000/mm3.
Bone marrow aspiration and biopsy revealed malignant
cells and necrosis (Figure 4A-D). We informed the pa-
tient of the diagnosis of bone marrow metastasis with
bronchial mucoepidermoid carcinoma. Unfortunately, on
the day he was scheduled to receive systemic chemother-
apy, the patient presented with severe respiratory tract
hemorrhage. Following rapid deterioration from the dis-
ease, he died on the 16th day of admission.
Discussion
Based on its histopathological features, we diagnosed
the present lung tumor as primary high-grade bronchial
mucoepidermoid carcinoma, which is relatively rare in
the lung. Histologically, it is believed that mucoepider-
moid carcinomas are derived from the serous and mucus
glands of the trachea and bronchi. They are classified as
low or high grade according to histological appearance,
Figure 3 Histological findings from lung biopsy showing high-grade bronchial mucoepidermoid carcinoma with mucin-secreting cells
and intermediate cells (A: hematoxylin-eosin (HE) stain, ×200). The tumor cells were positive for CK7, CK5/6, and TTF-1 (B-D: ×200).
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It is believed that the biological behavior is associated with
differentiation [5]. The prognosis of low-grade mucoepider-
moid carcinomas is much better. Only very few cases of
high-grade tumors with the malignant features of rapid de-
terioration and early distant metastases have extremely
poor prognosis [6].
Bronchial mucoepidermoid carcinoma always occurs in
the central bronchi. It appears on CT as an isolated, well-
defined oval or lobulated mass with smooth margins aris-
ing within the bronchus [7]. It may be associated with ob-
structive pneumonia and atelectasis, or in a few cases,
with cavitation and calcification. On CT imaging, the ma-
jority of these tumors exhibits moderate to markedTable 1 Laboratory test results




WBC 11,700/μL 9,900/μL 9,900/μL
RBC 3,470,000/mm3 2,020,000/mm3 1,340,000/mm3
HGB 10.5 g/dL 6.2 g/dL 4.2 g/dL
PLT 87,000/mm3 56,000/mm3 30,000/mm3
PT ND 13.2 s 19.7 s
APTT ND 24.8 s 52.5 s
Fibrinogen ND 1.0 g/L 0.56 g/L
D-dimer ND ND 0.457 mg/L
Coombs (DAT) ND ND Negative
APTT, activated partial thromboplastin time; DAT, direct antibody test; HGB,
hemoglobin; ND, not done; PLT, platelet count; PT, prothrombin time; RBC,
red blood cell; WBC, white blood cell.enhancement. However, the present tumor was mainly
located in the left inferior lobar bronchus and associated
with an oval, spiculated mass in the peripheral lung tissue,
a multicenter origin considered very rare.
Poorly differentiated bronchial mucoepidermoid carcin-
oma may present with the highly malignant biological
characteristics of regional lymph node metastases. How-
ever, distant metastases, especially bone marrow metasta-
sis, are extremely rare, and have not been reported in the
available literature. Bone marrow metastasis occurs when
cancer cells from a non-hematological tumor infiltrate the
bone marrow via hematogenous spread or direct exten-
sion from contiguous tumor deposits [8]. Malignant cells
in bone marrow smears and biopsy are a key diagnostic
feature. Patients typically present with anemia, bone pain,
fatigue, and progressive deterioration. Changes in the per-
ipheral blood are always obvious decreased HGB and PLT,
but normal or increased leukocytes [8].
Metastatic carcinoma in bone marrow in the exhaus-
tion phase is a rare pathophysiological form of bone
marrow metastasis. Featuring rapid onset, progressive
anemia, and thrombocytopenia accompanied by severe
hemorrhage, infection, and even disseminated intravas-
cular coagulation (DIC), it is considered a lethal compli-
cation of malignant tumor [8-10]. Due to the poor
performance status, systemic chemotherapy is often con-
sidered a relative contraindication for such patients. Thus,
the duration of survival maintained by only supportive
treatment is usually very limited [10].
The diagnosis of bone marrow metastasis in our pa-
tient was based on bone marrow smear and biopsy. The
Figure 4 Bone marrow smear (A, B: Wright-Giemsa stain, ×1,000) and biopsy (C, D: HE stain, ×400) showing metastatic tumor cells
and necrosis.
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thrombin time and activated partial thromboplastin time,
decreased fibrinogen, elevated D-dimer level) supported
the diagnosis of DIC. All clinical features and auxiliary
examinations were consistent with bone marrow failure
induced by metastatic carcinoma. Regrettably, we were un-
able to perform the bone marrow examination in time and
administer salvage chemotherapy to this patient in view
of his personal wishes and rapid deterioration from the
disease.
Conclusions
This case demonstrates the ability of primary high-grade
bronchial mucoepidermoid carcinoma to metastasize to
the bone marrow, which, as has been the case in many
other tumors, might be a poor prognostic factor in
mucoepidermoid carcinoma. Thus, we suggest consider-
ing the probability of bone marrow metastasis if there is
progressive PLT and HGB decline without any obvious
reason. Bone marrow aspiration and biopsy should be
performed to confirm diagnosis as soon as possible. Re-
gardless, timely salvage chemotherapy may prolong sur-
vival and improve the prognosis.
Consent
We obtained written informed consent from the next of
kin of the patient for publication of this case report and
any accompanying images. A copy of the written consent
is available for review by the Editor-in-Chief of this
journal.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ZYP, GZY, and LHD contributed equally to this work; participated in the
care of the patient, data collection, and literature search; and drafted the
manuscript. LMQ, TTY, and ZHD reviewed the CT images and photographed
the bone marrow pathology. All authors participated in the conception and
design of the study. ZYP and GZY wrote the first draft of the manuscript. All
authors read and approved the final manuscript.
Authors’ information
Zhenyu Pan and Guozi Yang are co-first authors.
Acknowledgments
We thank Dr. Hongguang Zhao for her expert technical assistance about
bone scintigraphy.
Author details
1Department of Radiotherapy, Norman Bethune First Hospital, Jilin University,
71 Xinmin Street, Changchun 130021, China. 2Department of Pathology,
Norman Bethune First Hospital, Jilin University, 71 Xinmin Street, Changchun
130021, China. 3Department of Radiology, Norman Bethune First Hospital,
Jilin University, 71 Xinmin Street, Changchun 130021, China. 4Cancer Center,
Norman Bethune First Hospital, Jilin University, 71 Xinmin Street, Changchun
130021, China.
Received: 3 September 2013 Accepted: 9 May 2014
Published: 21 May 2014
References
1. Leonardi HK, Jung-Legg Y, Legg MA, Neptune WB: Tracheobronchial
mucoepidermoid carcinoma. J Thorac Cardiovasc Surg 1978, 76:431–438.
2. Yousem S, Nicholson A: Mucoepidermoid carcinoma. In World Health
Organization classification of tumours.Pathology and genetics of tumours
of the lung, pleura, thymus and heart. Edited by Travis W, Brambilla E,
Muller-Hermlink H, Harris C. Lyon: IARC; 2004:63–64.
3. Liu X, Adams AL: Mucoepidermoid carcinoma of the bronchus: a review.
Arch Pathol Lab Med 2007, 131:1400–1404.
Pan et al. World Journal of Surgical Oncology 2014, 12:158 Page 5 of 5
http://www.wjso.com/content/12/1/1584. Hashemzade S, Taghizadieh A, Rashidi F, Esmaeili HA, Mohammadreza G:
Mucoepidermoid carcinoma of trachea in a 22 years old woman: a case
report. Pneumologia 2011, 60:164–165.
5. Yousem SA, Hochholzer L: Mucoepidermoid tumors of the lung. Cancer
1987, 60:1346–1352.
6. Shimizu J, Watanabe Y, Oda M, Morita K, Tsunezuka Y, Nonomura A:
Clinicopathologic study of mucoepidermoid carcinoma of the lung.
Int Surg 1998, 83:1–3.
7. Li X, Zhang W, Wu X, Sun C, Chen M, Zeng Q: Mucoepidermoid carcinoma
of the lung: common findings and unusual appearances on CT. Clin
Imaging 2012, 36:8–13.
8. Xiao L, Luxi S, Ying T, Yizhi L, Lingyun W, Quan P: Diagnosis of unknown
nonhematological tumors by bone marrow biopsy: a retrospective
analysis of 10,112 samples. J Cancer Res Clin Oncol 2009, 135:687–693.
9. Ozkan M, Er O, Karahan IO, Deniz K, Coşkun R, Küçük C, Yurci A, Altinbaş M:
Rectal carcinoid tumor with bone marrow and osteoblastic bone
metastasis: a case report. Turk J Gastroenterol 2007, 18:111–114.
10. Krishnan C, George TI, Arber DA: Bone marrow metastases: a survey of
nonhematologic metastases with immunohistochemical study of
metastatic carcinomas. Appl Immunohistochem Mol Morphol 2007, 15:1–7.
doi:10.1186/1477-7819-12-158
Cite this article as: Pan et al.: Bone marrow metastasis in primary
bronchial mucoepidermoid carcinoma: a case report. World Journal of
Surgical Oncology 2014 12:158.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
